Compare PACB & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PACB | PFL |
|---|---|---|
| Founded | 2000 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Finance Companies |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.8M | 395.7M |
| IPO Year | 2010 | 2003 |
| Metric | PACB | PFL |
|---|---|---|
| Price | $1.22 | $7.71 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.67 | N/A |
| AVG Volume (30 Days) | ★ 6.2M | 181.5K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $93,468,000.00 | N/A |
| Revenue This Year | $11.32 | N/A |
| Revenue Next Year | $12.14 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.04 | N/A |
| 52 Week Low | $0.85 | $7.60 |
| 52 Week High | $2.73 | $8.70 |
| Indicator | PACB | PFL |
|---|---|---|
| Relative Strength Index (RSI) | 38.82 | 31.76 |
| Support Level | $1.20 | $7.60 |
| Resistance Level | $1.40 | $8.50 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 18.66 | 16.28 |
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. The company seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.